The new tariff structure for the Swiss ambulatory setting submitted to the Federal Council

26

Jul 2019

As MTRC described in January 2019, The outpatient medical services are currently billed via TARMED, which includes all the benefits of compulsory health insurance. TARMED is an outdated structure; Thus, curafutura, an association of health insurance companies in Switzerland, started the initiative to change the current outpatient pricing structure (TARMED) in 2016.

Ats-tms SA was founded at the beginning of 2016 by curafutura, the Federation of Swiss physicians (FMH), the association of Swiss hospitals (H+, who left ats-tms SA after the validation of benefit structure) and the medical tariff commission (MTK/CTM) in order to develop a thoroughly revised tariff structure for ambulatory medical benefits and to be able to update it regularly.

On July 12, 2019, the Swiss Medical Tariff Commission (MTK/CTM), announced that the new tariff structure for the ambulatory sector, TARDOC, is ready to replace TARMED. The Medical Professional Association (FMH) and curafutura, the other involved partners, delivered TARDOC to the Federal Council for approval.

The new structure represents the services provided as an outpatient procedure and includes about 2800 positions spread over 70 chapters and divided according to the regions of the body. It is already available to the public and can be seen here.

FMH and curafutura recognize the principle of cost neutrality pursuant to Article 59c, point 1, letter C of the Health Insurance Ordinance (KVV/OAMal). However, service providers and insurers have different ideas on how to implement the transition from TARMED to TARDOC in compliance with this principle. Therefore, two variants have been presented that are distinguished only by the number of tariff points.

The TARDOC structure is expected to enter into force on January 1, 2021.

See the communication posted by the MTK/CTM here in Italian (change to French or German in the top right corner) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more